SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Sick Visit — Julius Caesar
| Patient | Julius Caesar |
|---|
| Date of birth | 1972-07-12 |
|---|
| Identifiers | MRN HR-AC001-SYN; SSN (made up) 000-01-6022 |
|---|
| Document date | 2026-09-08 |
|---|
| Author | Lucius Fairbanks-Okonkwo, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Sore throat, blocked nose, cough, and a low fever for three days; asking what he can take for the cold. [S]
History of Present Illness
Julius Caesar is a 54-year-old man with focal epilepsy from a chronic left temporal cortical infarct, on levetiracetam 500 mg twice daily for three weeks, and with hypertension and hyperlipidemia on lisinopril, atorvastatin, and aspirin, who came in the same day with three days of sore throat, a blocked and runny nose, a cough with a little clear phlegm, and a temperature up to 37.9 C at home. Several of his staff have had colds. He has slept badly for two nights because of the cough and a run of evening events. He has had no spell, no warning feelings, and no headache beyond a mild frontal ache with the congestion, and he has taken every dose of levetiracetam. He has no breathlessness, chest pain, or ear pain. He asks whether he can take a decongestant cold remedy and ibuprofen, which he used before. He has no new weakness, numbness, speech, or vision change. [S]
| Element | Detail |
|---|
| Onset | Three days ago |
| Symptoms | Sore throat, nasal congestion and discharge, cough with clear phlegm, temperature to 37.9 C |
| Context | Colds among his staff; two nights of poor sleep |
| Seizures | None; no missed levetiracetam doses |
| Pertinent negatives | No breathlessness, chest pain, ear pain, or new neurological symptom |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Positive | Low fever and tiredness; no rigors |
| Ears, nose, mouth, and throat | Positive | Sore throat, blocked and runny nose; no ear pain |
| Respiratory | Positive | Cough with clear phlegm; no breathlessness or wheeze |
| Cardiovascular | Negative | No chest pain or palpitations |
| Neurological | Negative | No spell, aura, weakness, numbness, speech or vision change; mild frontal ache with congestion |
| Psychiatric | Negative | A little irritable from poor sleep; mood otherwise steady |
6 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Lisinopril 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth each morning | Oral route | 2026-08-04 | active | S |
| Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily | 500 mg twice daily, morning and evening | Oral route | 2026-08-18 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth at bedtime | One tablet by mouth at bedtime | Oral route | 2026-08-18 | active | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth daily | One tablet by mouth daily with food | Oral route | 2026-08-18 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for fever or sore throat (no more than 3 g a day) | One or two tablets every 6 hours as needed, at most 3 g a day, for up to a week | Oral route | 2026-09-08 to 2026-09-14 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-09-08 | Body height | 182 | cm | S |
| 2026-09-08 | Body weight | 75.4 | kg | S |
| 2026-09-08 | Body mass index (BMI) [Ratio] | 22.8 | kg/m2 | S |
| 2026-09-08 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-09-08 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-09-08 | Heart rate | 84 | /min | S |
| 2026-09-08 | Respiratory rate | 16 | /min | S |
| 2026-09-08 | Body temperature | 37.8 | Cel | S |
| 2026-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Physical Exam
Vital signs recorded on 2026-09-08; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Tired but well; temperature 37.8 C; oxygen saturation 97 percent |
| Ears, nose, and throat | Nasal mucosa swollen with clear discharge; pharynx red without exudate; tonsils not enlarged; ear drums normal |
| Neck | Small tender anterior cervical nodes |
| Respiratory | Clear to auscultation; no wheeze or crackles |
| Cardiovascular | Regular rhythm; blood pressure 136/86 mmHg |
| Neurological | Alert and oriented; no focal deficit |
| Point-of-care tests | Rapid antigen tests for COVID-19 and influenza A and B negative |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Recurrent transient episodes of collapse: six days ago a witnessed collapse with stiffening and jerking of both arms for about a minute, a bitten tongue, and about twenty minutes of confusion, after a rising strange feeling and dizziness; two briefer spells of staring and unresponsiveness in the past eighteen months; cause not yet known (seizure, convulsive syncope, or transient ischemic attack) | resolved | confirmed |
R56.9 | S — Synthetic presenting problem anchored to the documented accounts of falling attacks and fainting fits; it resolves when the cause is found. |
| Hypertension, stage 2: 152/94 and 148/92 mmHg today; told of high blood pressure about three years ago and never treated | active | confirmed |
I10 | S — Synthetic vascular risk factor; no blood pressure from his lifetime is known. |
| Hyperlipidemia: LDL 158 mg/dL, triglycerides 170 mg/dL, HDL 44 mg/dL | active | confirmed |
E78.5 | S — Synthetic vascular risk factor; no lipid value from his lifetime is known. |
| Focal epilepsy with a structural vascular cause: focal impaired-awareness seizures with automatisms, one evolving to a bilateral tonic-clonic seizure, arising from a chronic left temporal cortical infarct, with left temporal sharp waves on EEG | active | confirmed |
G40.209 | S — Synthetic modern diagnosis anchored to the documented falling attacks; the ILAE 2017 seizure types and a structural cause are chosen for teaching and make no claim about what he had. |
| Chronic left posterior temporal cortical infarct, not recognized before the seizures, with moderate small-vessel white matter disease and a non-stenotic left carotid plaque; no residual deficit | active | confirmed |
I69.398 | S — Synthetic modern finding anchored to the retrospective cerebrovascular hypothesis; it makes no claim about his real brain. |
| Acute viral upper respiratory infection with low-grade fever and poor sleep, three weeks after starting levetiracetam; rapid COVID-19 and influenza tests negative; resolved | active | confirmed |
J06.9 | S — Synthetic intercurrent illness, chosen to teach cold-remedy choices with hypertension, aspirin, and an antiseizure medicine, and sleep loss as a seizure trigger; it echoes no documented illness. |
Assessment and Plan
- Acute viral upper respiratory infection (J06.9). A viral cold with low fever. Negative rapid tests; no signs of streptococcal pharyngitis (cough, no exudate), sinusitis, or pneumonia, so no antibiotic. The cough began with the cold, so it is not the dry cough that lisinopril can cause; if a dry cough outlasts the cold, that will be reconsidered. [S]
- Acetaminophen 500 to 1000 mg every 6 hours as needed, no more than 3 g a day.
- Avoid decongestants (pseudoephedrine and phenylephrine), which raise blood pressure, and ibuprofen and other NSAIDs, which raise blood pressure and add bleeding risk with aspirin.
- Avoid sedating antihistamines, which add to the drowsiness levetiracetam can cause; use saline nasal rinses, honey, and fluids instead.
- Return or call for breathlessness, fever above 38.5 C for more than three days, or symptoms lasting beyond ten days.
- Focal epilepsy on levetiracetam (G40.209). No seizure; every dose taken. Fever and lost sleep both lower the seizure threshold. [S]
- Continue levetiracetam 500 mg twice daily; do not skip doses while unwell.
- Cancel evening events this week and sleep at least seven hours.
- Seizure action plan unchanged; staff know what to do.
- Hypertension on lisinopril (I10). 136/86 mmHg with a fever; above target, to be reassessed when well. [S]
- Continue lisinopril 10 mg; review at next week's visit.
Guideline basis: Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025)
Follow-up: Four-week chronic-care visit next week as scheduled; sooner for the warning signs above. Next scheduled visit 2026-09-15: four-week review of levetiracetam, blood pressure, the second rhythm monitor, mood, and cognition. [S]